Hainan Shuangcheng Pharmaceuticals News

In-depth research on Shuangcheng Pharmaceutical (002693): The peptide drug business is developing steadily and the prospects for endogenous and epitaxial expansion are promising

東吳證券Feb 15, 2016 00:00

Shuangcheng Pharmaceutical (002693) Review report: the performance meets expectations and is optimistic about the company's extension transformation.

廣證恆生Jan 15, 2016 00:00

[Guangzhou Securities Hang Seng Consulting] Shuangcheng Pharmaceutical Review report: the performance is in line with expectations and is optimistic about the company's extension transformation.

廣證恆生諮詢Jan 14, 2016 00:00

Shuangcheng Pharmaceutical Industry (002693) report comments: the acceleration of endogenous and epitaxial development is in line with expectations.

西南證券Aug 3, 2015 00:00

Shuangcheng Pharmaceutical Industry (002693): profit growth points will tend to be diversified

國泰君安Dec 22, 2013 00:00

[Guotai Junan Securities] Shuangcheng Pharmaceutical Industry: profit growth points will tend to be diversified

國泰君安Dec 20, 2013 00:00

[Huaan Securities] Shuangcheng Pharmaceutical Co., Ltd.: comments on New shares

華安證券Aug 8, 2012 00:00

[Everbright Securities] Shuangcheng Pharmaceutical: A Leading Company Building Peptide Pharmaceuticals

光大證券Aug 7, 2012 00:00

[northeast Securities] Shuangcheng Pharmaceutical Industry: a steady growth of Chemical synthetic Peptide Pharmaceutical Enterprises

東北證券Aug 1, 2012 00:00

[CSC FINANCIAL CO.,LTD] Shuangcheng Pharmaceutical Co., Ltd.: fight for spring alone

中信建投證券Aug 1, 2012 00:00

【中航证券】双成药业:技术领先的多肽类药物生产企业

中航證券Jul 31, 2012 00:00

新股申购策略20120731

中山證券Jul 31, 2012 00:00

【渤海证券】双成药业新股询价报告:多肽行业领军者蓄势待发

渤海證券Jul 26, 2012 00:00

【长江证券】双成药业:专注合成肽领域的优势企业

長江證券Jul 26, 2012 00:00

【招商证券】双成药业IPO投资价值分析报告:多肽仿制药制剂领先者

招商證券Jul 26, 2012 00:00

【国都证券】双成药业新股研究:多肽药物领域生力军,畅享行业高景气

國都證券Jul 26, 2012 00:00

【日信证券】双成药业:多肽药物行业的领先企业

日信證券Jul 26, 2012 00:00

【申银万国证券】双成药业:化学合成多肽药物细分市场领先者

申萬宏源Jul 26, 2012 00:00

【东方证券】双成药业:化学合成多肽领域领先企业

東方證券Jul 26, 2012 00:00

【广发证券】双成药业:储备丰富的多肽药物骨干企业

廣發證券Jul 24, 2012 00:00